ELV
Elevance Health Inc.
$426.79
+1.62
(+0.38%)
Mkt Cap
92.68B
Volume
0
52W Range
273.71-436.24
Sector
Healthcare
Beta
0.68
EPS (TTM)
23.51
P/E Ratio
18.15
Revenue (TTM)
200.41B
Rev Growth (5Y)
+10.3%
EPS Growth (5Y)
+6.7%
AlphaVal · Fair Value
What we estimate one share is worth
$418.04
Overvalued
weak signal
2.1% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B-
Stable Earnings Power
66.1 / 100 composite
Steady, predictable earnings power — graded A–F vs. similar companies.
Company Description
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 199.12B | 176.81B | 171.34B | 156.59B | 138.64B | 121.87B | 104.21B | 92.11B | 90.04B | 84.98B | 79.24B | 73.92B |
| Net Income | 5.66B | 5.98B | 5.99B | 5.89B | 6.10B | 4.57B | 4.81B | 3.75B | 3.84B | 2.47B | 2.56B | 2.57B |
| EPS | 25.18 | 25.81 | 25.38 | 24.56 | 25.25 | 18.23 | 18.81 | 14.53 | 14.70 | 9.39 | 9.73 | 9.31 |
| Free Cash Flow | 3.17B | 4.55B | 6.76B | 7.25B | 7.28B | 9.67B | 4.98B | 2.62B | 3.39B | 2.62B | 3.51B | 2.74B |
| FCF / Share | 14.31 | 19.55 | 29.03 | 30.20 | 29.85 | 38.54 | 19.51 | 10.30 | 13.26 | 9.94 | 13.45 | 10.23 |
| Operating CF | 4.29B | 5.81B | 8.06B | 8.40B | 8.36B | 10.69B | 6.06B | 3.83B | 4.18B | 3.20B | 4.12B | 3.37B |
| Total Assets | 121.49B | 116.89B | 108.93B | 102.75B | 97.46B | 88.28B | 78.25B | 72.47B | 71.46B | 66.39B | 63.06B | 62.93B |
| Total Debt | 33.23B | 32.70B | 26.65B | 25.80B | 24.89B | 21.84B | 21.21B | 19.21B | 19.93B | 15.73B | 15.86B | 15.04B |
| Cash & Equiv | 9.49B | 8.29B | 6.53B | 7.39B | 4.88B | 5.74B | 4.94B | 3.93B | 3.61B | 4.08B | 2.11B | 2.15B |
| Book Value | 43.88B | 41.31B | 39.31B | 36.24B | 36.06B | 33.20B | 31.73B | 28.54B | 26.50B | 25.10B | 23.04B | 24.25B |
| Return on Equity | 0.13 | 0.14 | 0.15 | 0.16 | 0.17 | 0.14 | 0.15 | 0.13 | 0.14 | 0.10 | 0.11 | 0.11 |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 50.18B | 49.75B | 50.71B | 49.78B | 48.89B | 45.44B | 45.15B | 43.65B | 42.58B | 42.65B | 42.85B | 43.67B |
| Net Income | 1.76B | 547.00M | 1.19B | 1.74B | 2.18B | 418.00M | 1.02B | 2.30B | 2.25B | 856.00M | 1.29B | 1.85B |
| EPS | 8.00 | 2.47 | 5.32 | 7.72 | 9.64 | 1.84 | 4.36 | 9.91 | 9.65 | 3.67 | 5.48 | 7.83 |
| Free Cash Flow | 4.10B | (209.00M) | 775.00M | 1.79B | 821.00M | 384.00M | 2.35B | 124.00M | 1.70B | (3.30B) | 2.29B | 1.60B |
| FCF / Share | 18.58 | -0.94 | 3.43 | 7.91 | 3.63 | 1.69 | 10.06 | 0.53 | 7.30 | -14.15 | 9.75 | 6.76 |
| Operating CF | 4.33B | 84.00M | 1.14B | 2.05B | 1.02B | 706.00M | 2.68B | 447.00M | 1.98B | (2.97B) | 2.61B | 1.95B |
| Total Assets | 125.83B | 121.49B | 122.75B | 121.94B | 119.72B | 116.89B | 116.53B | 112.99B | 111.89B | 108.93B | 110.48B | 109.17B |
| Total Debt | 31.84B | 33.23B | 32.10B | 30.19B | 30.00B | 32.70B | 27.15B | 27.69B | 26.45B | 26.65B | 26.41B | 26.74B |
| Cash & Equiv | 9.66B | 9.49B | 8.71B | 8.56B | 7.50B | 8.29B | 7.87B | 6.50B | 6.23B | 6.53B | 10.92B | 9.99B |
| Book Value | 43.90B | 43.88B | 43.95B | 43.72B | 42.50B | 41.31B | 43.77B | 42.19B | 40.61B | 39.31B | 38.42B | 38.20B |
| Return on Equity | 0.04 | 0.01 | 0.03 | 0.04 | 0.05 | 0.01 | 0.02 | 0.05 | 0.06 | 0.02 | 0.03 | 0.05 |
ELV News
Will Health Benefits Weakness Drag Elevance's Q2 Earnings?
Eyes On Elevance Health, UnitedHealth For Continued Insurer Rebound
Elevance and UnitedHealth Earnings Are Next Test for Hot Health Insurer Stocks
Elevance Health: Defense For An Undervalued Price
Is ELV's Capital Allocation Strategy Creating Long-Term Value?
Curious about Elevance Health (ELV) Q2 Performance? Explore Wall Street Estimates for Key Metrics
3 Cheap Medical Stocks to Buy as US-Iran Tensions Keep Markets on Edge
Analysts Estimate Elevance Health (ELV) to Report a Decline in Earnings: What to Look Out for
Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2026 Results on July 15, 2026
Can Elevance Recover $115 Million Through Its CMS Lawsuit?